The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Have big data changed the view on AML risk classification?

Jun 16, 2020

During the 25th Congress of the European Hematology Association (EHA), the AML Hub spoke to Lars Bullinger, Charité – Universitätsmedizin Berlin, Berlin, DE. We asked: Have big data changed the view on AML risk classification?

In recent years, the prognostic value of molecular markers has been established, with six already incorporated into the European LeukemiaNet guidelines. This recent compilation of datasets across Europe has provided additional prognostic information and promises to better assist treatment decisions and improve patient outcomes.

Have big data changed the view on AML risk classification?